Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
28.46 48.80 81.21 88.21

+8 more quarters

P/S ratio
3.46 5.06 7.38 8.61
P/FCF ratio
39.72 37.87 57.15 53.31
P/Operating CF
119.35 129.05 109.09 172.83
P/B ratio
7.42 11.27 13.20 15.69
Price to Tangible BV
8.40 12.93 14.85 17.70
EV/Sales
3.59 5.22 7.47 8.72
EV/EBITDA
17.83 25.17 35.85 41.91
EV/Operating CF
21.45 24.47 35.53 41.20
EV/FCF
41.28 39.08 57.81 53.94
Quick Ratio
1.51 1.49 1.81 1.88
Current Ratio
2.48 2.49 2.81 2.87
Net Debt/EBITDA
2.64 3.15 1.37 1.84
Debt/Assets
29.96% 31.74% 29.75% 33.50%
Debt/Equity
0.67 0.73 0.63 0.73
Asset Turnover
0.92 0.89 0.86 0.83
Operating CF/Net income
0.93 1.25 1.80 1.43
Capex/Depreciation
(1.40) (1.06) (6.12) (1.41)
Interest Coverage
9.61 8.31 9.75 7.54
Research and Development Expense of Revenue
10.99% 11.78% 11.60% 10.93%
Selling, General and Administrative Expense of Revenue
43.01% 41.64% 42.29% 44.63%
Intangible Assets out of Total Assets
0.05 0.06 0.05 0.05
Share Based Compensation of Revenue
2.44% 2.80% 2.59% 2.36%
Graham Net Nets
0.01 0.00 0.01 0.01
Graham Number
49.70 42.44 41.19 39.36
Earnings Yield
3.51% 2.05% 1.23% 1.13%
Free Cash Flow Yield
2.52% 2.64% 1.75% 1.88%
Revenue per Share
11.57 10.88 11.14 10.04
Operating CF per Share
1.28 1.63 2.61 1.79
Capex per Share
(0.54) (0.40) (2.12) (0.44)
Free Cash Flow per Share
0.74 1.23 0.48 1.34
Cash per Share
7.72 6.86 10.18 10.76
Shareholders Equity per Share
20.52 18.61 21.54 19.67
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
20.52 18.61 21.54 19.67
Free Cash Flow
51.10 86.00 33.90 94.60
Working Capital
1,104.90 1,022.00 1,233.90 1,211.70
Capital Expenditures
(37.30) (27.80) (149.40) (31.10)
Net Current Asset Value
106.20 24.90 238.80 214.30
EV/EBIT
21.26 29.88 42.69 50.30
Capex to Sales
0.05 0.04 0.19 0.04
Price to Operating Income
20.46 28.96 42.20 49.71
Other line items
Average Receivables
516.60 473.50 441.20 418.90
Average Payables
109.70 103.70 47.40 44.25
Average Inventory
465.85 451.65 441.50 445.60
Average Assets
3,317.15 3,252.25 3,139.05 3,027.35
Average Common Equity
1,442.60 1,316.65 1,363.45 1,251.15

Fold the line items

Columns are period end dates